<DOC>
	<DOCNO>NCT00008320</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness ceramide cream treat woman cutaneous breast cancer .</brief_summary>
	<brief_title>Ceramide Cream Treating Women With Cutaneous Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine objective response rate woman cutaneous breast cancer treat topical ceramide cream . II . Determine time progression patient treat regimen . III . Determine toxicity regimen patient . IV . Assess quality life patient treat regimen . OUTLINE : Topical ceramide cream apply cutaneous lesion twice daily . Courses repeat every 28 day absence disease progression unacceptable toxicity . Quality life assess baseline 1 3 month . Patients follow every 3 month 1 year every 6 month 4 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm cutaneous breast cancer curative significantly palliative therapy exist include chest wall radiotherapy Measurable disease Disease progression least 1 hormonal therapy estrogen receptor positive disease radiotherapy chest wall disease previously irradiate No infection site cutaneous metastatic disease Hormone receptor status : Estrogen receptor status know PATIENT CHARACTERISTICS : Age : 18 Sex : Female Menopausal status : Not specify Performance status : ECOG 03 Life expectancy : At least 12 week Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent biologic therapy first 2 month study Chemotherapy : No concurrent local antineoplastic therapy cutaneous disease No concurrent systemic chemotherapy first 2 month study Endocrine therapy : See Disease Characteristics Radiotherapy : See Disease Characteristics At least 4 week since prior radiotherapy No concurrent radiotherapy first 2 month study except CNS disease Surgery : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
</DOC>